Pawel Kalinski

Immunologic Factors Associated with Differential Response to Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer

M. Nesline, S. Pabla, Shengle Zhang, 2024, Journal of personalized medicine.

Antagonism of regulatory ISGs enhances the anti-melanoma efficacy of STING agonists

W. Storkus, Jianmin Wang, Jessica N. Filderman, 2024, Frontiers in immunology.